Literature DB >> 25252316

Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis.

Matti Penttilä1, Erika Jääskeläinen1, Noora Hirvonen1, Matti Isohanni1, Jouko Miettunen1.   

Abstract

BACKGROUND: Duration of untreated psychosis (DUP) is one of the few potentially modifiable predictors of outcomes of schizophrenia. Long DUP as a predictor of poor short-term outcome has been addressed in previous meta-analyses, but the long-term effects of DUP remain unclear. AIMS: To analyse the associations between DUP and long-term outcomes of schizophrenia.
METHOD: A systematic literature search was performed using seven electronic databases and manual searches. Random effects weighted meta-analysis with correlation coefficients was used to pool the results.
RESULTS: We identified 3493 unique publications, from which 33 samples met our predefined selection criteria. Long DUP correlated statistically significantly with poor general symptomatic outcome, more severe positive and negative symptoms, lesser likelihood of remission and poor social functioning and global outcome (correlations 0.13-0.18). Long DUP was not associated with employment, quality of life or hospital treatment.
CONCLUSIONS: The small but mostly consistent correlation between long DUP and poor outcome indicates that early intervention in psychosis may have at least subtle positive effects on the long-term course of illness. Royal College of Psychiatrists.

Entities:  

Mesh:

Year:  2014        PMID: 25252316     DOI: 10.1192/bjp.bp.113.127753

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  138 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project.

Authors:  Michele Poletti; Lorenzo Pelizza; Silvia Azzali; Federica Paterlini; Sara Garlassi; Ilaria Scazza; Luigi Rocco Chiri; Eva Gebhardt; Simona Pupo; Raballo Andrea
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-12-01       Impact factor: 4.785

Review 3.  Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.

Authors:  Robert C Smith; Stefan Leucht; John M Davis
Journal:  Psychopharmacology (Berl)       Date:  2018-11-30       Impact factor: 4.530

4.  Reducing Stigma Toward Individuals With Schizophrenia Using a Brief Video: A Randomized Controlled Trial of Young Adults.

Authors:  Doron Amsalem; Lawrence H Yang; Samantha Jankowski; Sarah A Lieff; John C Markowitz; Lisa B Dixon
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

5.  Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors:  Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-19       Impact factor: 5.270

6.  First Presentation With Psychotic Symptoms in a Population-Based Sample.

Authors:  Gregory E Simon; Karen J Coleman; Bobbi Jo H Yarborough; Belinda Operskalski; Christine Stewart; Enid M Hunkeler; Frances Lynch; David Carrell; Arne Beck
Journal:  Psychiatr Serv       Date:  2017-01-03       Impact factor: 3.084

7.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

8.  An Examination of the Community Participation Interests of Young Adults with Serious Mental Illnesses.

Authors:  Elizabeth C Thomas; Gretchen Snethen; Amber O'Shea; John Suarez; Irene Hurford; Mark S Salzer
Journal:  J Behav Health Serv Res       Date:  2020-10       Impact factor: 1.505

Review 9.  Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders.

Authors:  Donald Addington; Sabina Abidi; Iliana Garcia-Ortega; William G Honer; Zahinoor Ismail
Journal:  Can J Psychiatry       Date:  2017-07-21       Impact factor: 4.356

10.  Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients.

Authors:  Frauke Schultze-Lutter; Jonas Rahman; Stephan Ruhrmann; Chantal Michel; Benno G Schimmelmann; Wolfgang Maier; Joachim Klosterkötter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-09       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.